SCOTTSDALE, Ariz., May 16, 2007 (PRIME NEWSWIRE) -- TASER International, Inc. (Nasdaq:TASR), a market leader in advanced electronic control devices announced today the publication of a study by Cleveland Clinic. According to the peer reviewed study published in Europace, by the European Society of Cardiology(r), a standard electrical discharge from a TASER(r) X26 electronic control device (ECD) does not affect the integrity of implantable pacemakers and defibrillators and did not trigger an implantable cardioverter defibrillator (ICD) shock in devices programmed to the standard non-committed shock delivery mode.
